RYANODEX dantrolene sodium is a Intravenous Injection, Suspension in the Human Prescription Drug category. It is labeled and distributed by Eagle Pharmaceuticals, Inc.. The primary component is Dantrolene Sodium.
Product ID | 42367-540_651d74ad-433d-4ac8-a7cd-7d79460b08ac |
NDC | 42367-540 |
Product Type | Human Prescription Drug |
Proprietary Name | RYANODEX dantrolene sodium |
Generic Name | Dantrolene Sodium |
Dosage Form | Injection, Suspension |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2014-07-23 |
Marketing Category | NDA / NDA |
Application Number | NDA205579 |
Labeler Name | Eagle Pharmaceuticals, Inc. |
Substance Name | DANTROLENE SODIUM |
Active Ingredient Strength | 250 mg/5mL |
Pharm Classes | Decreased Striated Muscle Contraction [PE],Decreased Striated Muscle Tone [PE],Skeletal Muscle Relaxant [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |
Marketing Start Date | 2014-07-23 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA205579 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2014-07-23 |
Ingredient | Strength |
---|---|
DANTROLENE SODIUM | 250 mg/5mL |
SPL SET ID: | 8f7b3ac0-604d-4c78-b545-5e0f8ea3d698 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
42023-123 | Dantrium | dantrolene sodium |
42023-124 | Dantrium | dantrolene sodium |
42023-125 | Dantrium | dantrolene sodium |
0115-4411 | Dantrolene Sodium | Dantrolene Sodium |
0115-4422 | Dantrolene Sodium | Dantrolene Sodium |
0115-4433 | Dantrolene Sodium | Dantrolene Sodium |
0527-3219 | Dantrolene Sodium | dantrolene sodium |
0527-3220 | Dantrolene Sodium | dantrolene sodium |
0527-3221 | Dantrolene Sodium | dantrolene sodium |
0904-7211 | Dantrolene Sodium | Dantrolene Sodium |
42023-144 | dantrolene sodium | dantrolene sodium |
49884-362 | dantrolene sodium | dantrolene sodium |
49884-363 | dantrolene sodium | dantrolene sodium |
49884-364 | dantrolene sodium | dantrolene sodium |
50268-217 | Dantrolene Sodium | Dantrolene Sodium |
55154-7140 | Dantrolene Sodium | Dantrolene Sodium |
63629-2168 | dantrolene sodium | dantrolene sodium |
63629-2169 | dantrolene sodium | dantrolene sodium |
63629-2170 | dantrolene sodium | dantrolene sodium |
64850-840 | Dantrolene Sodium | dantrolene sodium |
64850-841 | Dantrolene Sodium | dantrolene sodium |
64850-842 | Dantrolene Sodium | dantrolene sodium |
68084-300 | Dantrolene Sodium | Dantrolene Sodium |
27505-003 | Revonto | dantrolene sodium |
42367-540 | RYANODEX | dantrolene sodium |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
RYANODEX 87328851 not registered Live/Pending |
Lytropic Therapeutics, Inc. 2017-02-08 |
RYANODEX 87328847 not registered Live/Pending |
Lytropic Therapeutics, Inc. 2017-02-08 |
RYANODEX 78792827 3277753 Live/Registered |
Lyotropic Therapeutics, Inc. 2006-01-17 |